Itacitinib has been used in trials studying the treatment of Melanoma, Carcinoma, Metastatic Cancer, Endometrial Cancer, and B-cell Malignancies, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.